Paper of the Year

CHS PAPER OF THE YEAR WINNERS

2018

Paper of the Year: Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty

Published: The New England Journal of Medicine February 22, 2018 vol. 378: 699-707

Author(s): David R. Anderson, M.D., et al

Departments of Medicine (D.R.A.), Surgery (M.D.), and Community Health and Epidemiology (P.A.), Dalhousie University, and the Nova Scotia Health Authority

2017

Paper of the Year: A 17-gene stemness score for rapid determination of risk in acute leukemia

Published: Nature 2016; 540:433-437; 15 December 2016

Author(s): Stanley W.K. Ng, et al

University of Toronto and Princess Margaret Cancer Centre

University Health Network, Toronto

2016

Paper of the Year: Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation

Published The LANCET, 17, February, 2016

Author(s): Irwin Walker MD

Professor of Medicine, McMaster University

Juravinski Hospital and Cancer Centre

2015

Paper of the Year: Screening for Occult Cancer in Unpro-voked Venous Thromboembolism

Published: New England Journal of Medicine June 22, 2015, at NEJM.org

Author(s): Dr. Marc Carrier

The Ottawa Hospital, General Campus 501 Smyth Road, Box 201A Ottawa Ontario K1H 8L6 Canada

2014 TRANSLATIONAL/BASIC CATEGORY

Paper of the Year: “Identification of pre-leukaemic Haematopoietic stem cells in acute leukaemia”

Published: Nature, Volume: 506, Pages: 328–333 (20 February 2014)

Author(s): Liran I Shlush MD PhD

Ontario Cancer Institute Toronto Canada

Clinical Fellow Leukemia Service

Princess Margaret Cancer Center, Toronto, Canada

2014 CLINICAL CATEGORY

Paper of the Year: “Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial”

Published: The Lancet, Volume 384, Issue 9955, Pages 1673 – 1683 (8 November 2014)

Author(s): M A Rodger MD

Thrombosis Program, Division of Hematology

Department of Medicine, University of Ottawa

Ottawa Hospital Research Institute, Ottawa, ON, Canada